Skip to content

Drug interactions

Denosumab + Leflunomide

Severity: Moderate

Denosumab and Leflunomide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents affect immune function, and denosumab labeling warns of serious infections, including in patients on immunosuppressants. Combined use may increase infection risk.

What this interaction means in plain words

Denosumab and Leflunomide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Denosumab belongs to Oncology; Leflunomide belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Additive immunosuppressive effects: leflunomide inhibits lymphocyte proliferation and denosumab inhibits RANKL signaling, which is also involved in immune function.

What to do

Monitor for signs of infection and treat promptly. Assess infection risk before starting denosumab in patients on leflunomide.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Denosumab and Leflunomide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Denosumab with Leflunomide?

MediHelp rates the interaction as moderate. Denosumab and Leflunomide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents affect immune function, and denosumab labeling warns of serious infections, including in patients on immunosuppressants. Combined use may increase infection risk.

How serious is the interaction between Denosumab and Leflunomide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of infection and treat promptly. Assess infection risk before starting denosumab in patients on leflunomide.

What other medicines interact with Leflunomide?

MediHelp also lists interactions of Leflunomide with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Leflunomide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in